Metsera Tanks; Instacart Soars; Tyson Foods Rallies

On this episode of Stock Movers:
- Metsera (MTSR) shares tank in premarket trading after Novo Nordisk A/S declined to further raise its offer for the US maker of an experimental weight-loss drug, bringing a bidding war with Pfizer Inc. to an end. Novo, the maker of Wegovy and Ozempic, decided to drop out of the running for Metsera on Saturday after Pfizer matched its latest offer in a takeover battle that had caused concern the bidders might be overpaying for an unproven asset. Adding to Novo’s obstacles, Metsera said it got a call from the US Federal Trade Commission flagging potential regulatory risks with the proposed Novo deal structure.
- Instacart (CART) shares soared ahead of the US market open after the online grocery company reported third-quarter results that beat expectations, indicating that demand for its core grocery delivery service has been holding strong. Orders grew 14% to 83.4 million in the July-to-September period, the company said in a shareholder letter on Monday. Wall Street was expecting 82.9 million, according to Bloomberg-compiled estimates. Total revenue, which also includes sales from advertising and enterprise software for grocers, was $939 million, again beating expectations.
- Tyson Foods (TSN) rallied in early trading despite the company saying it expects results for next year to be little changed as its beef segment continues to lose money, even as the Trump administration points to the meatpacking industry for driving up prices. The US’s biggest meatpacker sees adjusted operating income of $2.1 billion to $2.3 billion for fiscal 2026, compared to $2.29 billion this year. That’s as the beef segment is expected to see an adjusted operating loss of $400 million to $600 million next year, compared to $426 million this year.

See omnystudio.com/listener for privacy information.